BioAge Labs, Inc. (BIOA)

BioAge Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	334.47	21.64	27.64
Cash & Short-Term Investments	334.47	21.64	27.64
Cash Growth	1109.93%	-21.70%	-
Prepaid Expenses	1.99	0.35	0.39
Restricted Cash	-	3.31	-
Total Current Assets	336.47	25.31	28.03
Property, Plant & Equipment	0.81	0.52	0.37
Long-Term Investments	0.1	0.1	-
Other Long-Term Assets	-	-	0.03
Total Assets	337.38	25.92	28.43
Accounts Payable	2.1	1.87	2.26
Accrued Expenses	8.97	6.55	3.36
Short-Term Debt	-	38.86	-
Current Portion of Long-Term Debt	6	6	0.17
Current Portion of Leases	0.27	0.19	0.05
Current Unearned Revenue	-	3.31	-
Other Current Liabilities	1.74	1.39	0.02
Total Current Liabilities	19.08	58.17	5.86
Long-Term Debt	3.94	8.2	2.25
Other Long-Term Liabilities	0.61	0.23	0.15
Total Liabilities	23.63	66.6	8.27
Additional Paid-In Capital	545.32	8.14	5.12
Retained Earnings	-231.68	-181.7	-117.85
Comprehensive Income & Other	0.11	0.16	0.17
Total Common Equity	313.75	-173.4	-112.56
Shareholders' Equity	313.75	-40.67	20.16
Total Liabilities & Equity	337.38	25.92	28.43
Total Debt	10.21	53.25	2.47
Net Cash (Debt)	324.26	-31.61	25.18
Net Cash Per Share	151.43	-18.90	15.06
Filing Date Shares Outstanding	35.85	1.67	1.67
Total Common Shares Outstanding	34.2	1.67	1.67
Working Capital	317.39	-32.86	22.17
Book Value Per Share	9.17	-103.62	-67.33
Tangible Book Value	313.75	-173.4	-112.56
Tangible Book Value Per Share	9.17	-103.62	-67.33
Machinery	1.03	0.74	0.58

Source: S&P Capital IQ. Standard template. Financial Sources.